NYSE:HLI - Houlihan Lokey Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$52.01 -0.51 (-0.97 %)
(As of 06/21/2018 01:49 PM ET)
Previous Close$51.87
Today's Range$51.16 - $52.12
52-Week Range$34.16 - $52.86
Volume14,468 shs
Average Volume377,536 shs
Market Capitalization$3.43 billion
P/E Ratio21.67
Dividend Yield2.08%
Beta0.61
Houlihan Lokey logoHoulihan Lokey, Inc., an investment banking company, provides mergers and acquisitions (M&A), financings, financial restructurings, and financial advisory services in the United States, Canada, Europe, Asia, Australia, the Middle East, Latin America, and Africa. Its Corporate Finance segment offers general financial advisory services on M&A and capital markets offerings; advises public and private institutions on buy-side and sell-side transactions, leveraged loans, private mezzanine debt, high-yield debt, initial public offerings, follow-ons, convertibles, equity private placements, private equity, and liability management transactions; and advises financial sponsors on various transactions. This segment also provides financing solutions and capital-raising advisory services for publicly-held and multinational corporations, financial sponsors, and privately-held companies. The company's Financial Restructuring segment advises creditors and debtors in connection with recapitalization/deleveraging transactions. It also provides a range of advisory services, including structuring, negotiation, and confirmation on plans of reorganization; structuring and analysis of exchange offers; corporate viability assessment; litigation support and expert testimony; and procuring debtor-in-possession financing. Its Financial Advisory segment provides valuations of various assets and liabilities, including companies, illiquid debt and equity securities, and intellectual property. The company's financial advisory services also provides fairness opinions in connection with M&A and other transactions, and solvency opinions in connection with corporate spin-offs and dividend recapitalizations; and strategic consulting services and dispute resolution services. It serves corporations, financial sponsors, and government agencies. The company was founded in 1972 and is headquartered in Los Angeles, California.

Receive HLI News and Ratings via Email

Sign-up to receive the latest news and ratings for HLI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Investment advice
Sub-IndustryN/A
SectorFinance
SymbolNYSE:HLI
CUSIPN/A
Phone310-788-5200

Debt

Debt-to-Equity Ratio0.01
Current Ratio0.72
Quick Ratio0.72

Price-To-Earnings

Trailing P/E Ratio21.67
Forward P/E RatioN/A
P/E Growth1.3

Sales & Book Value

Annual Sales$963.36 million
Price / Sales3.57
Cash Flow$2.4638 per share
Price / Cash21.11
Book Value$12.58 per share
Price / Book4.13

Profitability

EPS (Most Recent Fiscal Year)$2.39
Net Income$172.28 million
Net Margins17.88%
Return on Equity19.69%
Return on Assets13.04%

Miscellaneous

Employees1,228
Outstanding Shares66,180,000

Houlihan Lokey (NYSE:HLI) Frequently Asked Questions

What is Houlihan Lokey's stock symbol?

Houlihan Lokey trades on the New York Stock Exchange (NYSE) under the ticker symbol "HLI."

How often does Houlihan Lokey pay dividends? What is the dividend yield for Houlihan Lokey?

Houlihan Lokey declared a quarterly dividend on Wednesday, May 9th. Investors of record on Monday, June 4th will be paid a dividend of $0.27 per share on Friday, June 15th. This represents a $1.08 annualized dividend and a yield of 2.08%. The ex-dividend date is Friday, June 1st. This is an increase from Houlihan Lokey's previous quarterly dividend of $0.20. View Houlihan Lokey's Dividend History.

How will Houlihan Lokey's stock buyback program work?

Houlihan Lokey announced that its Board of Directors has initiated a stock repurchase plan on Thursday, April 6th 2017, which authorizes the company to repurchase $50,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire up to 2.3% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company's board of directors believes its stock is undervalued.

How were Houlihan Lokey's earnings last quarter?

Houlihan Lokey (NYSE:HLI) announced its earnings results on Wednesday, May, 9th. The financial services provider reported $0.65 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.58 by $0.07. The financial services provider had revenue of $244.75 million for the quarter, compared to analysts' expectations of $236.68 million. Houlihan Lokey had a net margin of 17.88% and a return on equity of 19.69%. The company's revenue was down 4.8% compared to the same quarter last year. During the same period in the prior year, the business posted $0.59 EPS. View Houlihan Lokey's Earnings History.

What price target have analysts set for HLI?

5 equities research analysts have issued 12 month target prices for Houlihan Lokey's shares. Their forecasts range from $42.00 to $54.00. On average, they expect Houlihan Lokey's share price to reach $49.40 in the next year. View Analyst Ratings for Houlihan Lokey.

Who are some of Houlihan Lokey's key competitors?

Who are Houlihan Lokey's key executives?

Houlihan Lokey's management team includes the folowing people:
  • Mr. Irwin N. Gold, Exec. Chairman & Sr. MD (Age 61)
  • Mr. Scott L. Beiser, CEO, Sr. MD & Member of Board of Directors (Age 58)
  • Mr. David A. Preiser, Co-Pres & Sr. Managing Director of Financial Restructuring Group (Age 60)
  • Scott J. Adelson, Co-Pres, Global Co-Head of Corp. Fin. & Director (Age 57)
  • Mr. Jeffrey Werbalowsky, Co-Chairman & Sr. MD

When did Houlihan Lokey IPO?

(HLI) raised $301 million in an initial public offering on Thursday, August 13th 2015. The company issued 13,100,000 shares at a price of $22.00-$24.00 per share. BofA Merrill Lynch and Goldman Sachs served as the underwriters for the IPO and UBS Investment Bank, Keefe, Bruyette & Woods (A Stifel Company), Houlihan Lokey, Sandler O'Neill + Partners and JMP Securities were co-managers.

Has Houlihan Lokey been receiving favorable news coverage?

Headlines about HLI stock have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Houlihan Lokey earned a news sentiment score of 0.15 on Accern's scale. They also gave media stories about the financial services provider an impact score of 44.68 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near term.

Who are Houlihan Lokey's major shareholders?

Houlihan Lokey's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include HL VOTING TRUST (49.50%), ORIX HLHZ HOLDING LLC (49.40%), BlackRock Inc. (2.82%), Kayne Anderson Rudnick Investment Management LLC (1.94%), Neuberger Berman Group LLC (1.87%) and Burgundy Asset Management Ltd. (1.83%). Company insiders that own Houlihan Lokey stock include Christopher M Crain, David A Preiser, Irwin Gold, J Lindsey Alley, Orix Hlhz Holding Llc, Robert A Schriesheim, Scott Joseph Adelson and Scott L Beiser. View Institutional Ownership Trends for Houlihan Lokey.

Which major investors are selling Houlihan Lokey stock?

HLI stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., The Manufacturers Life Insurance Company , Thrivent Financial for Lutherans, Schroder Investment Management Group, JPMorgan Chase & Co., Smith Asset Management Group LP, Dupont Capital Management Corp and Franklin Resources Inc.. Company insiders that have sold Houlihan Lokey company stock in the last year include Christopher M Crain, Irwin Gold, J Lindsey Alley, Orix Hlhz Holding Llc, Scott Joseph Adelson and Scott L Beiser. View Insider Buying and Selling for Houlihan Lokey.

Which major investors are buying Houlihan Lokey stock?

HLI stock was bought by a variety of institutional investors in the last quarter, including Kayne Anderson Rudnick Investment Management LLC, Millennium Management LLC, Bamco Inc. NY, Stifel Financial Corp, Wells Fargo & Company MN, Neuberger Berman Group LLC, Natixis Advisors L.P. and Dimensional Fund Advisors LP. View Insider Buying and Selling for Houlihan Lokey.

How do I buy shares of Houlihan Lokey?

Shares of HLI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Houlihan Lokey's stock price today?

One share of HLI stock can currently be purchased for approximately $52.01.

How big of a company is Houlihan Lokey?

Houlihan Lokey has a market capitalization of $3.43 billion and generates $963.36 million in revenue each year. The financial services provider earns $172.28 million in net income (profit) each year or $2.39 on an earnings per share basis. Houlihan Lokey employs 1,228 workers across the globe.

How can I contact Houlihan Lokey?

Houlihan Lokey's mailing address is 10250 CONSTELLATION BLVD. 5TH FLOOR, LOS ANGELES CA, 90067. The financial services provider can be reached via phone at 310-788-5200 or via email at [email protected]


MarketBeat Community Rating for Houlihan Lokey (HLI)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  149 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  310
MarketBeat's community ratings are surveys of what our community members think about Houlihan Lokey and other stocks. Vote "Outperform" if you believe HLI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HLI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.